Gardere Client Rosewood Private Investments Announces Majority Investment in ProTec Laboratory

14 November 2017 News

Gardere client Rosewood Private Investments announced a majority equity investment in ProTec Laboratory, a leading provider of contract manufacturing services to consumer brands in the dietary supplements, sports nutrition, functional foods and pet care products industries.

“By bringing ProTec into the fold, we’ve created a significant platform of scale with enormous potential,” said Paul Richardson, CEO of Rosewood Private Investments’ holding company. “Today, the combined businesses serve well over 100 customers in over 60 markets globally, and we plan to grow far beyond that by focusing on our centers of excellence, as well as through select strategic acquisitions.”

Chris Converse, co-chair of Gardere’s Private Equity Team, and Christopher J. Babcock represented Rosewood Private Investments in the transaction. More information on the deal is available here, and additional background on various Rosewood investments are available via the Dallas Morning News.   

Related Services

Insights

Cryptocurrency in China is like BIG BROTHER in 1984!
20 October 2019
Internet, IT & e-Discovery Blog
California Governor Signs New Telehealth Insurance Law
18 October 2019
Health Care Law Today
Continued Increase in E-Commerce and Online Ordering Changes Landscape of Urban Transportation
17 October 2019
Dashboard Insights
CMS Proposes Revisions to Stark Law
16 October 2019
Health Care Law Today
PATH Summit 2019
18-20 December 2019
Arlington, VA
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.